Eric Anderson

This inventor holds 47 USPTO granted patents and 4 published patent applications, plus 13 CIPO patents and 12 EPO patents, primarily in Antioxidant Inflammation Modulators. Top assignees: Reata Pharmaceuticals, Inc., Edifire LLC, Reata Pharmaceuticals Holdings, LLC. Active years: 2008-2025.

USPTO Granted Patents = 47 (Patent Applications = 4)

% Patents Active = 76.6

CIPO Patents = 13 (Patent Applications = 11)

EPO Patents = 12 (Patent Applications = 8)

Average Co-Inventor Count = 3.2

ph-index = 21

Forward Citations = 905(Granted Patents)

Location History:

Houston, TX (US) (2008 - 2016)
Grafton, MA (US) (2015 - 2017)
Tempe, AZ (US) (2018 - 2020)
Southlake, TX (US) (2013 - 2024)

Company Filing History:

29 out of 63

Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals Holdings, LLC

patents

4. 2 out of 113

Hanchett Entry Systems, Inc.

Encysive Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Antioxidant

Inflammation Modulators

Oleanolic Acid

Pyrazolyl

Tricyclic Enones

Bardoxolone Methyl

Cerumen Removal

Triterpenoid Derivatives

Multi-Factor Authentication

Dynamic Media Negotiation

Secure Conferencing

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12358866 - Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 (2025-07-15),

2. 12065464 - 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof (2024-08-20),

3. 11919838 - Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 (2024-03-05),

4. 11814338 - Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators (2023-11-14),

5. 11192852 - Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators (2021-12-07),

6. 11091430 - Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17 (2021-08-17),

7. 11078230 - 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof (2021-08-03),

8. 10596106 - Compositions and methods for cerumen removal (2020-03-24),

9. 10573450 - Degauss circuit for use in an electronically actuated door lock (2020-02-25),

10. 10556858 - Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17 (2020-02-11),

11. 10501489 - C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof (2019-12-10),

12. 10093614 - Antioxidant Inflamation modulators: oleanolic acid derivatives with amino and other modifications at C-17 (2018-10-09),

13. 10026247 - Request to exit two-wire control module (2018-07-17),

14. 9884809 - Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators (2018-02-06),

15. 9796668 - Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use (2017-10-24),

Sure, I'd be happy to help you with that. Here is the article about inventor Eric Anderson:

Title: The Innovative Journey of Inventor Eric Anderson

Introduction:

Eric Anderson, a prolific inventor based in Southlake, Texas, has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions. With an impressive portfolio of 32 patents, Eric's work continues to push the boundaries of innovation in antioxidant inflammation modulation.

Latest Patents:

Eric Anderson's recent patents showcase his expertise in developing novel antioxidant inflammation modulators. One of his latest inventions includes oleanolic acid derivatives with amino and other modifications at C-17, opening new possibilities in pharmaceutical compositions and methods of using the compounds. Another notable patent is on pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators, highlighting his commitment to advancing therapeutic solutions.

Career Highlights:

Throughout his career, Eric Anderson has lent his expertise to renowned pharmaceutical companies such as Reata Pharmaceuticals, Inc. and Encysive Pharmaceuticals, Inc. His innovative approach and dedication to scientific research have earned him a reputation as a trailblazer in the industry.

Collaborations:

In his quest for innovation, Eric Anderson has collaborated with esteemed professionals in the field. Some of his notable coworkers include Xin Jiang and Melean Visnick, who have contributed to the success of his projects through their collective expertise and knowledge.

Conclusion:

In conclusion, Eric Anderson's impact on the pharmaceutical industry is undeniable, with a remarkable track record of patents that have revolutionized antioxidant inflammation modulation. His collaborations and career highlights further underscore his commitment to pushing the boundaries of innovation and driving positive change in the field.